Senores Pharmaceuticals Ltd.(NSE:SENORES)

Senores Pharmaceuticals Ltd. engages in the manufacture and sale of pharmaceutical and generic medicines. It operates through the following segments: Regulated Markets Business, Emerging Markets Business, Critical Care Injectables Business, API Business. The Regulated Markets Business segment involves in the contract development and manufacturing operations and contract manufacturing operations. The Emerging Markets Business segment provides the development, manufacturing and sale of pharmaceutical products. The Critical Care Injectables Business segment engages in the distribution of critical care injectables to hospitals. The API Business segment manufactures APIs for the domestic market and SAARC countries. The company was founded on December 26, 2017 and is headquartered in Ahmedabad, India.